REVIEW article
Front. Immunol.
Sec. Inflammation
This article is part of the Research TopicImmune Cell Dynamics in Chronic Inflammatory Diseases and Cancer ImmunopathologyView all 5 articles
Research Progress on the Role and Mechanism of Circadian Clock Gene PER1 in the Occurrence and Development of Multiple Diseases
Provisionally accepted- The Third Xiangya Hospital of Central South University, Changsha, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Circadian rhythm, an inherent 24-hour periodic rhythm in organisms, is regulated by circadian clock genes. As a key component of the transcription-translation feedback loop, the core circadian gene period (PER) 1, not only maintains circadian rhythm homeostasis but also plays a significant role in the pathophysiological processes of various human diseases. This review summarizes the biological characteristics and regulatory mechanisms of PER1, as well as its roles and molecular mechanisms in cardiovascular diseases, nervous system diseases, metabolic disorders, immune-related diseases, and tumors. In cardiovascular diseases, PER1 helps regulate blood pressure, renal function, and vascular inflammation. In the nervous system, it influences ischemic brain injury, sleep homeostasis, and neurodegenerative diseases. In metabolic disorders, PER1 modulates endocrine function, glucose-lipid metabolism, and energy balance. In immune-related diseases, it regulates immune cell functions and inflammatory signaling. In tumors, PER1 has tumor-suppressive effects, with low expression correlating to poor prognosis. This review highlights the critical role of PER1 as a core circadian gene in maintaining physiological homeostasis and regulating disease progression, providing a comprehensive perspective for understanding its complex functions in physiological and pathological processes, offering new insights for developing precision therapies targeting PER1 and its associated signaling pathways.
Keywords: Period 1, Circadian Rhythm, Immune System Diseases, tumors, Cardiovascular Diseases, Nervous System Diseases, metabolic disorders
Received: 29 Sep 2025; Accepted: 18 Nov 2025.
Copyright: © 2025 Zhao, Li, Lu, Huang, Chen, Tan and Gao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Lina Tan, tanlinawork@163.com
Lihua Gao, 49516596@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
